Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 807 of 1,261
  1. US 8765909

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  2. US 8765761

    6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor

    GILEAD CONNECTICUT, INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  3. US 8765731

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  4. US 8765176

    Method of manufacturing tablet

    Takeda Pharmaceutical Company Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  5. US 8765883

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  6. US 8765673

    Methods for promoting wound healing and/or reducing scar formation

    THE ARIZONA BOARD OF REGENTS · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  7. US 8765717

    Meloxicam and glucosamine formulation and uses thereof

    Monte Verde S.A. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  8. US 8765685

    Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

    HALOZYME, INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  9. US 8765665

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  10. US 8765437

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  11. US 8765671

    Methods and compositions for modulation of blood-neural barrier

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  12. US 8765813

    Use of treprostinil to treat and prevent ischemic lesions

    United Therapeutics Corporation · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  13. US 8765751

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  14. US 8765817

    Selective inhibitors of EG5 motors and methods of use

    Arrowhead Center, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  15. US 8765802

    Kinase inhibitors, compositions thereof, and methods of use therewith

    United States of America as represented by the Department of Health and Human Resources NIH · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  16. US 8765797

    TG2 inhibitors and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  17. US 8758311

    Transdermal patch with extensor means

    Nemaura Pharma Limited · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  18. US 8758723

    Compositions and methods for cellular imaging and therapy

    The Board of Regents of the University of Texas System · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  19. US 8759340

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  20. US 8759392

    Amides as inhibitors of human secreted phospholipase A2

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  21. US 8759332

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  22. US 8759314

    Methods for treating multiple sclerosis using antisense oligonucleotides

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  23. US 8759301

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  24. US 8758813

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.